theory clinical_30_1
imports Main

begin

typedecl entity
typedecl event

consts
  Mutation :: "entity ⇒ bool"
  CTNNB1 :: "entity ⇒ bool"
  Activating :: "entity ⇒ bool"
  Proliferation :: "entity ⇒ bool"
  Cell :: "entity ⇒ bool"
  βCatenin :: "entity ⇒ bool"
  Promote :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Patient :: "event ⇒ entity ⇒ bool"
  Via :: "entity ⇒ entity ⇒ bool"
  Inhibit :: "event ⇒ bool"
  CTNNB :: "entity ⇒ bool"
  Reduce :: "event ⇒ bool"
  Stop :: "event ⇒ bool"
  Cause :: "entity ⇒ entity ⇒ bool"
  Treat :: "event ⇒ bool"
  PatientEntity :: "entity ⇒ bool"  (* Renamed to avoid conflict with Patient as event *)

(* Explanation 1: Activating mutations of CTNNB1 promote proliferation of cells via β-catenin. *)
axiomatization where
  explanation_1: "∃x y z e. Mutation x ∧ CTNNB1 x ∧ Activating x ∧ Proliferation y ∧ Cell y ∧ βCatenin z ∧ Promote e ∧ Agent e x ∧ Patient e y ∧ Via y z"

(* Explanation 2: Inhibiting β-catenin can reduce or stop the proliferation of cells caused by activating mutations of CTNNB. *)
axiomatization where
  explanation_2: "∃x y z e1 e2. Inhibit e1 ∧ βCatenin x ∧ Proliferation y ∧ Cell y ∧ Mutation z ∧ CTNNB z ∧ Activating z ∧ (Reduce e2 ∨ Stop e2) ∧ Agent e2 x ∧ Patient e2 y ∧ Cause y z"

theorem hypothesis:
  assumes asm: "βCatenin x ∧ PatientEntity y ∧ Mutation y ∧ CTNNB1 y ∧ Activating y"
  (* Hypothesis: Inhibiting β-catenin may be effective in treating patients with activating CTNNB1 mutations. *)
  shows "∃x y e1 e2. Inhibit e1 ∧ βCatenin x ∧ PatientEntity y ∧ Mutation y ∧ CTNNB1 y ∧ Activating y ∧ Treat e2 ∧ Agent e2 x ∧ Patient e2 y"
proof -
  (* From the known information, we have βCatenin x, PatientEntity y, Mutation y, CTNNB1 y, and Activating y. *)
  from asm have "βCatenin x ∧ PatientEntity y ∧ Mutation y ∧ CTNNB1 y ∧ Activating y" by meson
  
  (* Explanation 1 states that activating mutations of CTNNB1 promote proliferation of cells via β-catenin. *)
  (* Explanation 2 states that inhibiting β-catenin can reduce or stop the proliferation of cells caused by activating mutations of CTNNB. *)
  (* We have a logical relation Implies(D, Not(B)), which means inhibiting β-catenin implies not proliferation of cells. *)
  (* This suggests that inhibiting β-catenin can counteract the effects of activating mutations of CTNNB1. *)
  
  (* To show that inhibiting β-catenin may be effective in treating patients with activating CTNNB1 mutations, *)
  (* we need to establish a connection between inhibiting β-catenin and treating the patient. *)
  (* Explanation 2 provides a basis for this by indicating that inhibiting β-catenin can reduce or stop proliferation. *)
  
  (* We can infer that if inhibiting β-catenin reduces or stops proliferation, it may be considered a treatment. *)
  have "Inhibit e1 ∧ βCatenin x ∧ PatientEntity y ∧ Mutation y ∧ CTNNB1 y ∧ Activating y ∧ Treat e2 ∧ Agent e2 x ∧ Patient e2 y" sledgehammer
  
  then show ?thesis <ATP>
qed

end
